Upgrade to SI Premium - Free Trial

Amgen (AMGN): Cutting PT On Broad Revenue Miss - BMO

October 26, 2017 6:32 AM
BMO Capital analyst, Ian Somaiya, reiterated his Market Perform rating on shares of Amgen (NASDAQ: AMGN) and cut his price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles